All Relations between Alzheimer Disease and microtubule-associated protein tau

Publication Sentence Publish Date Extraction Date Species
Zhong-Yuan Yu, Wei-Wei Li, Hai-Mei Yang, Noralyn B Mañucat-Tan, Jun Wang, Ye-Ran Wang, Bin-Lu Sun, Zi-Cheng Hu, Li-Li Zhang, Liang Tan, Juan Deng, Yu-Hui Li. Naturally Occurring Antibodies to Tau Exists in Human Blood and Are Not Changed in Alzheimer's Disease. Neurotoxicity research. vol 37. issue 4. 2020-12-21. PMID:32026360. naturally occurring antibodies to tau exists in human blood and are not changed in alzheimer's disease. 2020-12-21 2023-08-13 human
Zhong-Yuan Yu, Wei-Wei Li, Hai-Mei Yang, Noralyn B Mañucat-Tan, Jun Wang, Ye-Ran Wang, Bin-Lu Sun, Zi-Cheng Hu, Li-Li Zhang, Liang Tan, Juan Deng, Yu-Hui Li. Naturally Occurring Antibodies to Tau Exists in Human Blood and Are Not Changed in Alzheimer's Disease. Neurotoxicity research. vol 37. issue 4. 2020-12-21. PMID:32026360. hyperphosphorylated tau is an important pathological agent in alzheimer's disease (ad). 2020-12-21 2023-08-13 human
Md Sahab Uddin, Md Tanvir Kabir, Kamal Niaz, Philippe Jeandet, Christophe Clément, Bijo Mathew, Abdur Rauf, Kannan R R Rengasamy, Eduardo Sobarzo-Sánchez, Ghulam Md Ashraf, Lotfi Aley. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease. Molecules (Basel, Switzerland). vol 25. issue 6. 2020-12-21. PMID:32168835. alzheimer's disease (ad) is one of the utmost chronic neurodegenerative disorders, which is characterized from a neuropathological point of view by the aggregates of amyloid beta (aβ) peptides that are deposited as senile plaques and tau proteins which form neurofibrillary tangles (nfts). 2020-12-21 2023-08-13 Not clear
Kumar B Rajan, Neelum T Aggarwal, Elizabeth A McAninch, Jennifer Weuve, Lisa L Barnes, Robert S Wilson, Charles DeCarli, Denis A Evan. Remote Blood Biomarkers of Longitudinal Cognitive Outcomes in a Population Study. Annals of neurology. vol 88. issue 6. 2020-12-21. PMID:32799383. the longitudinal association of the blood biomarkers total tau (t-tau), neurofilament light (nf-l), and glial fibrillary acidic protein (gfap) with common sporadic alzheimer disease (ad) and cognitive decline is not established. 2020-12-21 2023-08-13 Not clear
Yiyuan Xia, Zhi-Hao Wang, Jichun Zhang, Xia Liu, Shan Ping Yu, Karen X Ye, Jian-Zhi Wang, Keqiang Ye, Xiao-Chuan Wan. C/EBPβ is a key transcription factor for APOE and preferentially mediates ApoE4 expression in Alzheimer's disease. Molecular psychiatry. 2020-12-19. PMID:33339957. the apolipoprotein e ε4 (apoe4) allele is a major genetic risk factor for alzheimer's disease (ad), and its protein product, apoe4, exerts its deleterious effects mainly by influencing amyloid-β (aβ) and tau (neurofibrillary tangles, nfts) deposition in the brain. 2020-12-19 2023-08-13 mouse
Xuewen Xiao, Bin Jiao, Xinxin Liao, Weiwei Zhang, Zhenhua Yuan, Lina Guo, Xin Wang, Lu Zhou, Xixi Liu, Xinxiang Yan, Beisha Tang, Lu She. Association of Genes Involved in the Metabolic Pathways of Amyloid-β and Tau Proteins With Sporadic Late-Onset Alzheimer's Disease in the Southern Han Chinese Population. Frontiers in aging neuroscience. vol 12. 2020-12-18. PMID:33240075. association of genes involved in the metabolic pathways of amyloid-β and tau proteins with sporadic late-onset alzheimer's disease in the southern han chinese population. 2020-12-18 2023-08-13 Not clear
Xuewen Xiao, Bin Jiao, Xinxin Liao, Weiwei Zhang, Zhenhua Yuan, Lina Guo, Xin Wang, Lu Zhou, Xixi Liu, Xinxiang Yan, Beisha Tang, Lu She. Association of Genes Involved in the Metabolic Pathways of Amyloid-β and Tau Proteins With Sporadic Late-Onset Alzheimer's Disease in the Southern Han Chinese Population. Frontiers in aging neuroscience. vol 12. 2020-12-18. PMID:33240075. the genes involved in the metabolic pathways of amyloid-β (aβ) and tau proteins significantly influence the etiology of alzheimer's disease (ad). 2020-12-18 2023-08-13 Not clear
Rawan Tarawne. Biomarkers: Our Path Towards a Cure for Alzheimer Disease. Biomarker insights. vol 15. 2020-12-18. PMID:33293784. the updated research framework for ad, proposed by the national institute of aging- alzheimer's association (nia-aa) work group, emphasizes the importance of incorporating biomarkers in ad research and defines ad as a biological construct consisting of amyloid, tau, and neurodegeneration which spans pre-symptomatic and symptomatic stages. 2020-12-18 2023-08-13 human
Yahuan Lou, Colin Carlock, Jean W. Glymphatic Efficiency Is a Critical Factor for Using Abnormal Tau in Peripheral Tissues as Biomarker for Alzheimer's Disease. Biomarkers and applications. vol 2018. issue 3. 2020-12-18. PMID:33313483. glymphatic efficiency is a critical factor for using abnormal tau in peripheral tissues as biomarker for alzheimer's disease. 2020-12-18 2023-08-13 Not clear
Yahuan Lou, Colin Carlock, Jean W. Glymphatic Efficiency Is a Critical Factor for Using Abnormal Tau in Peripheral Tissues as Biomarker for Alzheimer's Disease. Biomarkers and applications. vol 2018. issue 3. 2020-12-18. PMID:33313483. alzheimer's disease or other dementias are characterized by the accumulation of abnormal tau and amyloid β peptides in brains. 2020-12-18 2023-08-13 Not clear
Anping Xu, Qingtao Zeng, Yinshan Tang, Xin Wang, Xiaochen Yuan, You Zhou, Zhigang L. Electroacupuncture Protects Cognition by Regulating Tau Phosphorylation and Glucose Metabolism via the AKT/GSK3β Signaling Pathway in Alzheimer's Disease Model Mice. Frontiers in neuroscience. vol 14. 2020-12-18. PMID:33328854. electroacupuncture protects cognition by regulating tau phosphorylation and glucose metabolism via the akt/gsk3β signaling pathway in alzheimer's disease model mice. 2020-12-18 2023-08-13 mouse
Margreet B Koopman, Stefan G D Rüdige. Alzheimer Cells on Their Way to Derailment Show Selective Changes in Protein Quality Control Network. Frontiers in molecular biosciences. vol 7. 2020-12-18. PMID:33330614. alzheimer's disease is driven by protein aggregation and is characterized by accumulation of tau protein into neurofibrillary tangles. 2020-12-18 2023-08-13 Not clear
David G Coughlin, Howard I Hurtig, David J Irwi. Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases. Movement disorders : official journal of the Movement Disorder Society. vol 35. issue 1. 2020-12-17. PMID:31660655. previous attempts to subtype patients within the spectrum of lewy body disorders have centered on clinical features, but converging evidence from studies of neuropathology and ante mortem biomarkers, including csf, neuroimaging, and genetic studies, suggest that alzheimer's disease beta-amyloid and tau copathology strongly influence clinical heterogeneity and prognosis in lewy body disorders. 2020-12-17 2023-08-13 Not clear
Boris-Stephan Rauchmann, Farhad Ghaseminejad, Shailaja Mekala, Robert Perneczk. Cerebral Microhemorrhage at MRI in Mild Cognitive Impairment and Early Alzheimer Disease: Association with Tau and Amyloid β at PET Imaging. Radiology. vol 296. issue 1. 2020-12-17. PMID:32368960. cerebral microhemorrhage at mri in mild cognitive impairment and early alzheimer disease: association with tau and amyloid β at pet imaging. 2020-12-17 2023-08-13 human
Boris-Stephan Rauchmann, Farhad Ghaseminejad, Shailaja Mekala, Robert Perneczk. Cerebral Microhemorrhage at MRI in Mild Cognitive Impairment and Early Alzheimer Disease: Association with Tau and Amyloid β at PET Imaging. Radiology. vol 296. issue 1. 2020-12-17. PMID:32368960. background growing evidence indicates an association between cerebral microhemorrhages (mhs) and amyloid β accumulation in alzheimer disease (ad), but to the knowledge of the authors the association with tau burden is unknown. 2020-12-17 2023-08-13 human
Chanung Wang, David M Holtzma. Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 45. issue 1. 2020-12-16. PMID:31408876. bidirectional relationship between sleep and alzheimer's disease: role of amyloid, tau, and other factors. 2020-12-16 2023-08-13 mouse
Jozef Hanes, Andrej Kovac, Hlin Kvartsberg, Eva Kontsekova, Lubica Fialova, Stanislav Katina, Branislav Kovacech, Eva Stevens, Jakub Hort, Martin Vyhnalek, Lynn Boonkamp, Michal Novak, Henrik Zetterberg, Oskar Hansson, Philip Scheltens, Kaj Blennow, Charlotte E Teunissen, Norbert Zilk. Evaluation of a novel immunoassay to detect p-tau Thr217 in the CSF to distinguish Alzheimer disease from other dementias. Neurology. vol 95. issue 22. 2020-12-16. PMID:32973122. to investigate whether tau phosphorylated at thr217 (p-tau t217) assay in csf can distinguish patients with alzheimer disease (ad) from patients with other dementias and healthy controls. 2020-12-16 2023-08-13 Not clear
Zhengyu Li, Li Gan, Si Yan, Yufang Yan, Wei Huan. Effect of C-phycocyanin on HDAC3 and miRNA-335 in Alzheimer's disease. Translational neuroscience. vol 11. issue 1. 2020-12-16. PMID:33312721. amyloid-beta (aβ) plaque deposits and neurofibrillary tangles containing tau proteins are the key pathognomonic manifestations of alzheimer's disease (ad). 2020-12-16 2023-08-13 Not clear
D-Y Liu, L Zhan. MicroRNA-132 promotes neurons cell apoptosis and activates Tau phosphorylation by targeting GTDC-1 in Alzheimer's disease. European review for medical and pharmacological sciences. vol 23. issue 19. 2020-12-15. PMID:31646584. microrna-132 promotes neurons cell apoptosis and activates tau phosphorylation by targeting gtdc-1 in alzheimer's disease. 2020-12-15 2023-08-13 Not clear
Nicola Spotorno, Julio Acosta-Cabronero, Erik Stomrud, Björn Lampinen, Olof T Strandberg, Danielle van Westen, Oskar Hansso. Relationship between cortical iron and tau aggregation in Alzheimer's disease. Brain : a journal of neurology. vol 143. issue 5. 2020-12-14. PMID:32330946. relationship between cortical iron and tau aggregation in alzheimer's disease. 2020-12-14 2023-08-13 human